OXFORD UNIVERSITY PRESS

Treatment Response and Resistance in Schizophrenia

ISBN : 9780198828761

参考価格(税込): 
¥3,652
著者: 
Oliver Howes
関連カテゴリー
ページ
240 ページ
フォーマット
Paperback
サイズ
138 x 216 mm
刊行日
2018年09月
シリーズ
Oxford Psychiatry Library
メール送信
印刷

Treatment resistant schizophrenia (TRS) is common, affecting approximately a third of patients diagnosed. Despite the prevalence of TRS, the best approach to practical management is often unclear to clinicians and patients. Treatment Response and Resistance in Schizophrenia offers a practical, clinically focused guide to TRS and the real-world challenges faced by those impacted. Over 14 chapters this resource covers the principles and practice of TRS, from the definition, epidemiology, and clinical assessment, to the pharmacological, physical, and psychological management of treatment resistance. All chapters have been written by internationally leading experts in the field to ensure busy clinicians have high-quality, applicable content that is rooted in real clinical experiences. A chapter of case studies is included to link real-life scenarios to each of the instructive chapters, illustrating approaches to practical management and application. Part of the Oxford Psychiatry Library, this useful pocket book is an invaluable resource and quick reference for psychiatrists, psychiatry trainees, and other mental health practitioners, as well as clinical psychologists, primary care physicians, and specialist nurses.

目次: 

1 Oliver Howes: Introduction
2 Robert McCutcheon, Christoph Correll, Oliver Howes, and John Kane: Treatment response and resistance in schizophrenia: principles and definition
3 Robert C. Smith, Stefan Leucht, and John M. Davis: Maximizing response to first-line antipsychotics in Schizophrenia
4 John Lally and James H. MacCabe: Epidemiology, impact and predictors of treatment resistant schizophrenia
5 Stephen J. Kaar, Steven Potkin, and Oliver Howes: The neurobiology of antipsychotic treatment response and resistance
6 Yvonne S. Yang, and Stephen R. Marder: Pharmacological management of TRS: Fundamentals of clozapine
7 Christopher Rohde and Jimmi Nielsen: Managing common adverse-effect of clozapine
8 Siobhan Gee and David Taylor: Pharmacological management of treatment-resistant schizophrenia: advanced use of clozapine
9 Thomas R. E. Barnes: Pharmacological management of TRS: alternatives to clozapine
10 Juliana Onwumere and Elizabeth Kuipers: Psychosis and the family: the role of family interventions
11 Majella Byrne, Suzanne Jolley & Emmanuelle Peters: Cognitive behavioral therapy for psychosis
12 Gary Remington, Ofer Agid, Hiroyoshi Takeuchi, Jimmy Lee, Araba Chintoh: Ultra treatment resistance
13 Ofer Agid, Thomas Barnes, Majella Byrne, Araba Chintoh, Christoph Correll, Siobhan Gee, Oliver Howes, Suzanne Jolley, John Lally, Jimmy Lee, John Kane, James MacCabe, Stephen R. Marder, Robert McCutcheon, Jimmi Nielsen, Emmanuelle Peters, Gary Remington, Christopher Rohde, Hiroyoshi Takeuchi, David Taylor, and Yvonne S. Yang: Illustrative case studies
14 Seiya Miyamoto and Nobumi Miyake: Novel treatments and future directions

著者について: 

Edited by Oliver Howes, King's College London, London, Professor of Molecular Psychiatry

Contributors:
Ofer Agid, Department of Psychiatry, University of Toronto, Toronto, Canada

Thomas R. E. Barnes, Emeritus Professor of Clinical Psychiatry, Imperial College London, London, UK

Majella Byrne, Department of Psychology, King's College London, London, UK

Araba Chintoh, Department of Psychiatry, University of Toronto, Toronto, Canada

Christoph U. Correll, Professor of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, New York, USA

John M. Davis, Psychiatric Institute, University of Illinois Medical School, and Maryland Psychiatric Research Center, Chicago and Baltimore, USA

Siobhan Gee, Principal Pharmacist, National Psychosis Unit and Liaison Psychiatry, South London and Maudsley NHS Foundation Trust, London, UK

Oliver Howes, Professor of Molecular Psychiatry, King's College London, London, Institute of Medical Sciences (Imperial College London) and Maudsley Hospital, London, UK

Suzanne Jolley, Department of Psychology, King's College London, London, UK

Elizabeth Kuipers, Institute of Psychiatry, Psychology & Neuroscience at King's College London, Department of Psychology, London, UK

Stephen J. Kaar, King's College London and Maudsley Hospital, London, UK

John Kane, Senior Vice President, Behavioral Health Services, Northwell Health, New York, USA

John Lally, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK

Stefan Leucht, Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany

Jimmy Lee, Institute of Mental Health, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

Robert McCutcheon, Wellcome Trust Clinical Research Training Fellow, King's College London, London, UK

James H. MacCabe, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK

Stephen Marder, UCLA Psychiatry & Biobehavioral Science, VA Greater LA Healthcare Sys, Los Angeles, USA

Seiya Miyamoto, Department of Psychiatry, Sakuragaoka Memorial Hospital, Tokyo, Japan

Nobumi Miyake, Department of Neuropsychiatry, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Japan

Jimmi Nielsen, Mental Health Centre Glostrup, Mental Health Services,Capital Region of Denmark, University of Copenhagen, Glostrup, Denmark

Juliana Onwumere, Institute of Psychiatry, Psychology & Neuroscience at King's College London, Department of Psychology, London, UK

Emmanuelle Peters, Reader in Clinical Psychology & PICuP Clinic Director, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK

Steven Potkin, Director Pharmacogenomics and Clinical Neuroscience, Long Beach Veterans Administration Health Care System, California, USA

Gary Remington, Department of Psychiatry, University of Toronto, Toronto, Canada; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Canada

Christopher Rohde, Mental Health Centre Glostrup, Mental Health Services, Capital Region of Denmark, University of Copenhagen, Glostrup, Denmark

Robert C. Smith, Department of Psychiatry New York University School of Medicine and Nathan Kline Institute for Psychiatric Research, New York, USA

Hiroyoshi Takeuchi, Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

David Taylor, Institute of Pharmaceutical Science, King's College London, London, UK

Yvonne Yang, UCLA Psychiatry & Biobehavioral Science/ VA Greater LA Healthcare Sys, Los Angeles, USA

このページに掲載の「参考価格」は日本国内における希望小売価格です。当ウェブサイトでのご購入に対して特別価格が適用される場合、販売価格は「割引価格」として表示されます。なお、価格は予告なく変更されることがございますので、あらかじめご了承ください。